Vitalzul

**Vitalzul** is a veterinary nutraceutical and developing pharmaceutical derived from blue scorpion venom extract, primarily developed for treating cancer in pets such as dogs and cats. It functions as an anti-angiogenic agent that inhibits blood vessel formation in solid tumors, leading to tumor size reduction, extended life expectancy, and improved quality of life with minimal observed toxicity. Originally commercialized in Cuba for human oncology as Escozine, PetLife Pharmaceuticals is advancing oral prescription-strength, intravenous, and injectable formulations for direct tumor administration, alongside preventive tabs and pet foods, positioning it as a non-invasive, cost-effective alternative to conventional cancer therapies like chemotherapy.[2][6][8]

Brand names

Vitalzul

Other names

Escozine